课题基金 / 基金详情

The role of CDKN2B in efferocytosis and atherosclerosis

The role of CDKN2B in efferocytosis and atherosclerosis
CDKN2B 在胞吞作用和动脉粥样硬化中的作用
批准号:
9247021
负责人:
Nicholas James Leeper
金额:
$40.36万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-04-10 至 2019-03-31
关键词:
9p21AffinityAgonistApolipoprotein EApoptosisApoptoticArterial Fatty StreakAtherosclerosisBehaviorBiological AssayBiologyBlood VesselsBone Marrow TransplantationCD47 geneCandidate Disease GeneCardiovascular DiseasesCardiovascular systemCause of DeathCell surfaceCellsChromosomesChromosomes, Human, Pair 9Coculture TechniquesCollaborationsConfocal MicroscopyCoronary ArteriosclerosisDataDevelopmentDisease modelEatingEmployee StrikesExcisionGene Expression ProfilingGenesGeneticGenetic PolymorphismGenetic VariationGenetic studyGrowthHeartHeart DiseasesHeritabilityHuman GeneticsHyperlipidemiaHypertensionImpairmentIn VitroIndividualInflammatoryInheritedKnock-outLeadLesionLigandsLinkLuciferasesMediatingMethodsMissionModelingMusNecrosisOralPPAR gammaPathologicPathway interactionsPatientsPhagocytesPhagocytosisPharmacogenomicsPhenocopyPhenotypePhosphatidylserinesPredispositionProcessReagentReporterResearch PersonnelRiskRisk FactorsRoleSafetyScientistSecondary toSeriesSignal TransductionSmokingSourceSpecific qualifier valueSpecificityTestingTissuesToxicologyTracerTransactivationTranslatingTumor Suppressor ProteinsUnited StatesUnited States National Institutes of HealthVariantVascular DiseasesWestern Worldatherogenesisbasecalreticulincardiovascular disorder riskdisorder riskgenome wide association studyhumanized antibodyin vivolifetime risklipid metabolismloss of functionmacrophagemimeticsmouse modelnovelnovel therapeuticspreventpublic health relevancereceptorrisk varianttransdifferentiation

项目摘要

项目成果

Nicholas James Leeper的其他基金

相似基金

相关文献

中文摘要
翻译
 描述(由申请人提供):全基因组关联研究(GWAS)最近发现,染色体9p21的一个区域是心血管疾病遗传风险的最重要来源。该基因座不受吸烟、高血压和高脂血症等传统风险因素的影响,最具预测性的9p21变异占个人一生患冠状动脉疾病风险的20%以上。尽管被认为是西方世界的主要死因,但这些基因多态性导致血管疾病的机制(S)仍不清楚。在这项提案中,研究人员试图阐明9p21风险基因的领先候选基因CDKN2B与动脉粥样硬化之间的关系。具体地说,他们将质疑该基因在一种被称为“胞吐作用”的过程中所扮演的角色,即吞噬细胞清除凋亡碎片的过程。他们将研究这一过程如何调节正在形成的动脉粥样硬化斑块中坏死核心的生长,并确定泡泡吞噬功能受损的下游后果。该提案将汇集来自多个领域的公认专家、高度专业化的翻译试剂和独特的小鼠模型,目的是全面描述CDKN2B的血管生物学。这项应用包括两个具体目标:1)使用新的谱系追踪和细胞特异性基因敲除模型来确定失败的吞噬信号如何调节正在形成的斑块中的前动脉粥样硬化表型转换;以及2)测试翻译的效用 一种新型的高亲和力人源化抗体,它可以刺激坏死性碎片的清除并诱导动脉粥样硬化斑块消退。这些研究的目的是“反向翻译”9p21基因座的生物学,并为后GWAS时代的心血管遗传学领域做出贡献。在这项提案的过程中所做的发现旨在支持国家卫生研究院所宣称的使命,并提供将导致 为心血管疾病患者开发新的转化性疗法。
英文摘要
 DESCRIPTION (provided by applicant): Genome-wide association studies (GWAS) have recently identified a region of chromosome 9p21 as the most important source of heritable risk for cardiovascular disease. This locus is independent of traditional risk factors such as smoking, hypertension and hyperlipidemia, and the most predictive 9p21 variants account for more than 20% of an individual's lifetime risk for coronary artery disease. Despite being implicated in the leading cause of death in the Western world, the mechanism(s) by which these polymorphisms lead to vascular disease remain unclear. In this proposal, the investigators seek to elucidate the relationship between a leading candidate gene at the 9p21 risk locus, CDKN2B, and atherosclerosis. Specifically, they will query the role of this gene in a process known as "efferocytosis", which is the phagocytic clearance of apoptotic debris. They will investigate how this process regulates the growth of the necrotic core in the developing atherosclerotic plaque and determine the downstream consequences of impaired efferocytosis. This proposal will bring together recognized experts from several fields, highly specialized translational reagents and unique mouse models with the objective of fully describing the vascular biology of CDKN2B. This application includes two specific aims which will: 1) Employ novel lineage tracing and cell-specific knockout models to determine how failed efferocytosis signaling regulates pro-atherosclerotic phenotype switching in the developing plaque; and 2) Test the translational utility of a novel high-affinity humanized antibody which may stimulate the removal of necrotic debris and induce atherosclerotic plaque regression. The objective of these studies is to 'reverse translate' the biology of the 9p21 locus and contribute to the field of cardiovascular genetics in the post-GWAS era. Discoveries made in the course of this proposal are intended to support the stated mission of the National Institutes of Health and provide contributions that will lead to the development of new translational therapies for patients with cardiovascular disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clonal expansion, resistance to efferocytosis and innate immunity in atherosclerosis
  • 批准号:
    10543819
  • 项目类别:
  • 资助金额:
    $85.4万
  • 财政年份:
    2019
  • 负责人:
    Nicholas James Leeper
  • 依托单位:
Clonal expansion, resistance to efferocytosis and innate immunity in atherosclerosis
  • 批准号:
    10327636
  • 项目类别:
  • 资助金额:
    $85.38万
  • 财政年份:
    2019
  • 负责人:
    Nicholas James Leeper
  • 依托单位:
The paradoxical role of CDKN2B in blood vessel sprouting and maturation
  • 批准号:
    9173040
  • 项目类别:
  • 资助金额:
    $46.66万
  • 财政年份:
    2014
  • 负责人:
    Nicholas James Leeper
  • 依托单位:
The paradoxical role of CDKN2B in blood vessel sprouting and maturation
  • 批准号:
    8968859
  • 项目类别:
  • 资助金额:
    $46.49万
  • 财政年份:
    2014
  • 负责人:
    Nicholas James Leeper
  • 依托单位:
海外基金